LYON, France, June 5, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced today that successful treatments have been performed at the St-Augustin Urology Clinic in Bordeaux, France utilizing EDAP's Ablatherm® High Intensity Focused Ultrasound (HIFU) for a focal approach to eradicate prostate cancer tumors.
